<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05010057</url>
  </required_header>
  <id_info>
    <org_study_id>UEC/2015/112/FHMS</org_study_id>
    <nct_id>NCT05010057</nct_id>
  </id_info>
  <brief_title>The Effect of New Zealand Blackcurrant (NZBC) Supplementation on Recovery Following Strenuous Exercise</brief_title>
  <acronym>CurraNZ_MD</acronym>
  <official_title>The Effect of New Zealand Blackcurrant (NZBC) Supplementation on Indices of Muscle Damage Following Strenuous Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Surrey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Surrey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to examine the effect of a New Zealand blackcurrant (NZBC) supplement on&#xD;
      markers of muscle damage and recovery following strenuous resistance exercise. The&#xD;
      investigation will compare responses between an experimental (NZBC capsule, 300 mg/day) and&#xD;
      placebo (PLA capsule, 300 mg sugar) group. Participants will attend a screening session where&#xD;
      they will consent to the study, complete a pre-activity medical questionnaire and have their&#xD;
      height, weight and resting blood pressure measured. If the participants meet the inclusion&#xD;
      criteria they will perform a familarisation session on the muscle strength assessment.&#xD;
      Participants will be randomized to NZBC or placebo groups, and consume one capsule in the&#xD;
      morning (between 6-10 am) for 12 days. This is a double-blinded study, which means that the&#xD;
      participant and the study team will not know which group the participants are assigned to&#xD;
      until the study is over. On day 8 participants will perform a strenuous bout of upper body&#xD;
      resistance exercise on the isokinetic dynamometer (exercise device). Muscle strength and&#xD;
      soreness, arm circumference, and elbow range of motion will be measured, and a fasted blood&#xD;
      sample will be collected, before and 24, 48, 72 &amp; 96 hours after the muscle fatigue protocol&#xD;
      (on days 9, 10, 11 &amp; 12). A marker of muscle damage (creatine kinase [CK] concentration) will&#xD;
      be measured in the blood samples. Participants will also be asked to complete a 6-day dietary&#xD;
      record, beginning on day 7 and ending on the final day of testing (day 12).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 10, 2016</start_date>
  <completion_date type="Actual">September 1, 2018</completion_date>
  <primary_completion_date type="Actual">September 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised, parallel design.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Coded, capsules</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in creatine kinase (CK) concentration at 72 hours post-exercise</measure>
    <time_frame>At baseline (pre-exercise) and 72 hours post-exercise.</time_frame>
    <description>Serum biomarker for muscle damage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in creatine kinase (CK) concentration at 96 hours post-exercise</measure>
    <time_frame>At baseline (pre-exercise) and 96 hours post-exercise..</time_frame>
    <description>Serum biomarker for muscle damage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in maximum voluntary contraction (MVC) from baseline to 96 hours post-exercise</measure>
    <time_frame>At baseline (pre-exercise) and post-exercise time points (at 0, 24, 48, 72 and 96 hours respectively).</time_frame>
    <description>Muscle function measure; maximal voluntary isometric contraction (torque, Nm) performed on isokinetic dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in rating of Delayed Onset of Muscle Soreness (DOMS) from baseline to 96 hours post-exercise</measure>
    <time_frame>At baseline (pre-exercise) and post-exercise time points (at 24, 48, 72 and 96 hours respectively).</time_frame>
    <description>Self-reported perception of muscle soreness using a visual analogue scale (VAS), from 'no soreness' [0 mm] on the left anchor point to 'extremely sore' [100 mm] on the right</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in joint range of motion (ROM) from baseline to 96 hours post-exercise</measure>
    <time_frame>At baseline (pre-exercise) and post-exercise time points (at 24, 48, 72 and 96 hours respectively).</time_frame>
    <description>Elbow ROM measured using a goniometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mid arm circumference (MAC) from baseline to 96 hours post-exercise</measure>
    <time_frame>At baseline (pre-exercise) and post-exercise time points (at 24, 48, 72 and 96 hours respectively).</time_frame>
    <description>Mid-upper arm circumference measured at the midpoint of the distance from the acromion process (acromiale) to the olecranon process (radiale).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Muscle Damage</condition>
  <arm_group>
    <arm_group_label>New Zealand blackcurrants (NZBC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 NZBC capsule (containing 300 mg active cassis containing 105 mg of anthocyanins, i.e. 35-50 % delphinidin-3-rutinoside, 5-20 % delphinidin-3-glucoside, 30-45 % cyanidin-3-rutinoside, 3-10 % cyanidin-3-glucoside), consumed in the morning, for 12 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (PLA)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 placebo capsule (containing 300 mg microcrystalline cellulose M102), consumed in the morning, for 12 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>New Zealand blackcurrants (NZBC)</intervention_name>
    <description>NZBC capsules containing anthocyanin-rich blackcurrant extract</description>
    <arm_group_label>New Zealand blackcurrants (NZBC)</arm_group_label>
    <other_name>NZBC extract supplement (Health Currancy Ltd [UK] / CurraNZ Ltd [NZ])</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo (PLA)</intervention_name>
    <description>Placebo capsules containing microcrystalline cellulose</description>
    <arm_group_label>Placebo (PLA)</arm_group_label>
    <other_name>Placebo capsules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and Females&#xD;
&#xD;
          -  18 - 45 years old&#xD;
&#xD;
          -  BMI: 19 - 29.9 kg/m2&#xD;
&#xD;
          -  Healthy: no active disease process that could interfere with endpoints measured as&#xD;
             determined by medical history&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking and tobacco use&#xD;
&#xD;
          -  Takes medication [excluding contraception]&#xD;
&#xD;
          -  BMI â‰¥ 30 kg/m2&#xD;
&#xD;
          -  Hypertensive (diastolic &gt; 90 and/or systolic blood pressure &gt; 140 mmHg)&#xD;
&#xD;
          -  History of musculoskeletal upper limb injuries&#xD;
&#xD;
          -  Performs regular resistance exercise (&gt; 2 sessions per week)&#xD;
&#xD;
          -  Uses dietary supplements that could influence muscle recovery or function (e.g.&#xD;
             protein supplements, antioxidants etc)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julie EA Hunt, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Surrey</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Surrey Human Performance Institute</name>
      <address>
        <city>Guildford</city>
        <state>Surrey</state>
        <zip>GU2 7AD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 6, 2021</study_first_submitted>
  <study_first_submitted_qc>August 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise-induced muscle damage</keyword>
  <keyword>Recovery</keyword>
  <keyword>Supplementation</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Anthocyanin</keyword>
  <keyword>New Zealand blackcurrant</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Will provide basic data spreadsheet upon request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

